SCHEMBL23256417

SCHEMBL23256417

COC(Cc1ccccc1)(C(N)=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ HIF1A Q16665 1/20 0.44
▸ CYP1A2 P05177 2/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ RECQL P46063 1/20 0.44
▸ MAPK1 P28482 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ CES1 P23141 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ KCNN4 O15554 2/20 0.41
▸ KIF11 P52732 2/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ TAAR1 Q96RJ0 1/20 0.40
▸ HTT P42858 1/20 0.39
▸ CHRM1 P11229 2/20 0.38
▸ EPHX1 P07099 1/20 0.38
▸ CHRM4 P08173 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5509050 0.85 MAPT (0.44) MAPTKMT2ASMN1; SMN2HIF1ACYP1A2
SCHEMBL6529359 0.83 MAPT (0.48) MAPTKMT2AHIF1ACYP1A2CYP2C19
SCHEMBL2190401 0.82 CES1 (0.56) KMT2ASMN1; SMN2HIF1ACYP1A2CYP3A4
SCHEMBL11247 0.80 KMT2A (0.46) MAPTKMT2AHIF1ACYP1A2CYP3A4
SCHEMBL11778520 0.78 CYP3A4 (0.42) MAPTKMT2ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL28753479 0.74 CES1 (0.44) MAPTKMT2ASMN1; SMN2HIF1ACYP1A2
SCHEMBL2845811 0.74 MAPT (0.55) MAPTKMT2ASMN1; SMN2HIF1ACYP1A2
SCHEMBL22406298 0.73 SMN1; SMN2 (0.44) MAPTKMT2ASMN1; SMN2HIF1ACYP1A2
SCHEMBL8459554 0.73 ALDH1A1 (0.44) SMN1; SMN2HIF1ACYP1A2CYP3A4RECQL
SCHEMBL29543860 0.73 CTBP2 (0.47) KMT2AHIF1ACYP1A2KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10987351-B2 RORgamma modulators and uses thereof GENFIT (FR) 2021-04-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10987351-B2 RORgamma modulators and uses thereof RORB, RORC, RORA MAPT 4111/4885KMT2A 2471/4885SMN1; SMN2 4792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback